Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol.
Saved in:
| Title: | Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol. |
|---|---|
| Authors: | Janssen, J. C.1,2 (AUTHOR), van Dijk, B.1 (AUTHOR), de Joode, K.1 (AUTHOR), Aarts, M. J. B.3 (AUTHOR), van den Berkmortel, F. W. P. J.4 (AUTHOR), Blank, C. U.5,6 (AUTHOR), Boers-Sonderen, M. J.7 (AUTHOR), van den Eertwegh, A. J. M.8 (AUTHOR), de Groot, J. W. B.9 (AUTHOR), Jalving, M.10 (AUTHOR), de Jonge, M. J. A.1 (AUTHOR), Joosse, A.1 (AUTHOR), Kapiteijn, E.6 (AUTHOR), Kamphuis-Huismans, A. M.11 (AUTHOR), Naipal, K. A. T.1 (AUTHOR), Piersma, D.12 (AUTHOR), Rikhof, B.13 (AUTHOR), Westgeest, H. M.14 (AUTHOR), Vreugdenhil, G.15 (AUTHOR), Oomen-de Hoop, E.1 (AUTHOR) |
| Source: | BMC Cancer. 5/23/2024, Vol. 24 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 177625751 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Janssen%2C+J%2E+C%2E%22">Janssen, J. C.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Dijk%2C+B%2E%22">van Dijk, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Joode%2C+K%2E%22">de Joode, K.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Aarts%2C+M%2E+J%2E+B%2E%22">Aarts, M. J. B.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Berkmortel%2C+F%2E+W%2E+P%2E+J%2E%22">van den Berkmortel, F. W. P. J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Blank%2C+C%2E+U%2E%22">Blank, C. U.</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boers-Sonderen%2C+M%2E+J%2E%22">Boers-Sonderen, M. J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+den+Eertwegh%2C+A%2E+J%2E+M%2E%22">van den Eertwegh, A. J. M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Groot%2C+J%2E+W%2E+B%2E%22">de Groot, J. W. B.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jalving%2C+M%2E%22">Jalving, M.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jonge%2C+M%2E+J%2E+A%2E%22">de Jonge, M. J. A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joosse%2C+A%2E%22">Joosse, A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kapiteijn%2C+E%2E%22">Kapiteijn, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kamphuis-Huismans%2C+A%2E+M%2E%22">Kamphuis-Huismans, A. M.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naipal%2C+K%2E+A%2E+T%2E%22">Naipal, K. A. T.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Piersma%2C+D%2E%22">Piersma, D.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rikhof%2C+B%2E%22">Rikhof, B.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Westgeest%2C+H%2E+M%2E%22">Westgeest, H. M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vreugdenhil%2C+G%2E%22">Vreugdenhil, G.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oomen-de+Hoop%2C+E%2E%22">Oomen-de Hoop, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 5/23/2024, Vol. 24 Issue 1, p1-7. 7p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177625751 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-12336-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 7 StartPage: 1 Titles: – TitleFull: Safe Stop IPI-NIVO trial: early discontinuation of nivolumab upon achieving a complete or partial response in patients with irresectable stage III or metastatic melanoma treated with first-line ipilimumab-nivolumab – study protocol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Janssen, J. C. – PersonEntity: Name: NameFull: van Dijk, B. – PersonEntity: Name: NameFull: de Joode, K. – PersonEntity: Name: NameFull: Aarts, M. J. B. – PersonEntity: Name: NameFull: van den Berkmortel, F. W. P. J. – PersonEntity: Name: NameFull: Blank, C. U. – PersonEntity: Name: NameFull: Boers-Sonderen, M. J. – PersonEntity: Name: NameFull: van den Eertwegh, A. J. M. – PersonEntity: Name: NameFull: de Groot, J. W. B. – PersonEntity: Name: NameFull: Jalving, M. – PersonEntity: Name: NameFull: de Jonge, M. J. A. – PersonEntity: Name: NameFull: Joosse, A. – PersonEntity: Name: NameFull: Kapiteijn, E. – PersonEntity: Name: NameFull: Kamphuis-Huismans, A. M. – PersonEntity: Name: NameFull: Naipal, K. A. T. – PersonEntity: Name: NameFull: Piersma, D. – PersonEntity: Name: NameFull: Rikhof, B. – PersonEntity: Name: NameFull: Westgeest, H. M. – PersonEntity: Name: NameFull: Vreugdenhil, G. – PersonEntity: Name: NameFull: Oomen-de Hoop, E. IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 05 Text: 5/23/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |